Genomic and Transcriptomic Landscape of Triple-Negative Breast Cancers: Subtypes and Treatment Strategies
2019 · Cancer Cell · 1,057 citations
https://doi.org/10.1016/j.ccell.2019.02.001
X
Xiangnan Li
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
101
Papers
2.6K
Citations
22
h-index
37
i10-index
Xiangnan Li is an academic researcher from Shanghai Jiao Tong University. The author has contributed to research in topics: Esophageal Cancer Research and Treatment & SARS-CoV-2 and COVID-19 Research & RNA modifications and cancer. The author has an h-index of 22, co-authored 86 publications.
ORCID: 0000-0002-3789-2861Papers by this author
worksLineage-specific pathogenicity, immune evasion, and virological features of SARS-CoV-2 BA.2.86/JN.1 and EG.5.1/HK.3
2024 · Nature Communications · 44 citations
https://doi.org/10.1038/s41467-024-53033-7
International expert consensus on immunotherapy for early-stage non-small cell lung cancer
2022 · Translational Lung Cancer Research · 24 citations
https://doi.org/10.21037/tlcr-22-617
Neutralization of SARS-CoV-2 BQ.1.1 and XBB.1.5 by Breakthrough Infection Sera from Previous and Current Waves in China
2023 · bioRxiv (Cold Spring Harbor Laboratory) · 9 citations
https://doi.org/10.1101/2023.02.07.527406
Analysis of factors influencing vascular calcification in peritoneal dialysis patients and their impact on long-term prognosis
2024 · BMC Nephrology · 2 citations
https://doi.org/10.1186/s12882-024-03582-2
GLIDR-mediated regulation of tumor malignancy and cisplatin resistance in non-small cell lung cancer via the miR-342-5p/PPARGC1A axis
2024 · BMC Cancer · 2 citations
https://doi.org/10.1186/s12885-024-12845-y
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat